Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Impairment of endothelial function in patients with multiple sclerosis.
Immunosuppressive monoclonal antibodies: current and next generation.
Enigmatic GPCR Finds a Stimulating Drug.
Theranostic implications of nanotechnology in multiple sclerosis: a future perspective.
Mechanisms of Immune Modulation By Mesenchymal Stromal Cells and Clinical Translation.
Pharyngeal electrical stimulation for dysphagia associated with multiple sclerosis: A pilot study.
Randomized trial of vaccination in fingolimod-treated patients with multiple sclerosis.
Cerebrospinal Fluid Flow Dynamics in Multiple Sclerosis Patients through Phase Contrast Magnetic Resonance Imaging.
[Basic mechanisms of action of fingolimod in relation to multiple sclerosis].
Selective ultrastructural vulnerability in the cuprizone-induced experimental demyelination.
Hypovitaminosis D association with disease activity in relapsing remitting multiple sclerosis in Brazil.
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study.
Multiple Sclerosis Increases Fracture Risk: A Meta-Analysis.
Pulmonary tuberculosis with neuromyelitis optica: an uncommon association of a common disease.
Neuregulin1-β Decreases IL-1β-Induced Neutrophil Adhesion to Human Brain Microvascular Endothelial Cells.
159 Microsurgical descending tractotomy in cases of intractable trigeminal pain syndromes.
Evaluation of the 9-item Patient Health Questionnaire (PHQ-9) as an assessment instrument for symptoms of depression in patients with multiple sclerosis.
Use of Neurofeedback to Enhance Response to Hypnotic Analgesia in Individuals With Multiple Sclerosis.
On the sex ratio of multiple sclerosis.
Trigger, pathogen, or bystander: the complex nexus linking Epstein- Barr virus and multiple sclerosis.
Recommendations for the detection and therapeutic management of cognitive impairment in multiple sclerosis.
3D GRASE arterial spin labelling reveals an inverse correlation of cortical perfusion with the white matter lesion volume in MS.
Differential regulation of central nervous system autoimmunity by T(H)1 and T(H)17 cells.
Cholesterol Modification of p40-Specific Small Interfering RNA Enables Therapeutic Targeting of Dendritic Cells.
Analysis of "task-positive" and "task-negative" functional networks during the performance of the Symbol Digit Modalities Test in patients at presentation with clinically isolated syndrome suggestive of multiple sclerosis.
Pages
« first
‹ previous
…
213
214
215
216
217
218
219
220
221
…
next ›
last »